accru
evid
green
tea
may
anticanc
activ
mechan
action
poorli
understood
green
tea
produc
shrub
camellia
sinensi
fig
leav
dri
ferment
green
color
attribut
polyphenol
retain
commerci
prepar
green
tea
extract
contain
polyphenol
polyphenol
sourc
bioflavonoid
strong
antioxid
activ
major
bioflavonoid
green
tea
epicatechin
like
bioflavonoid
tea
catechin
three
hydrocarbon
ring
hydroxyl
molecul
found
posit
fig
four
major
tea
catechin
epicatechin
ec
ec
ecg
epigallocatechin
egc
egc
egcg
rel
proport
ec
ecg
egc
egcg
nondecaffein
green
tea
mg
dri
wt
respect
correspond
proport
nondecaffein
black
tea
mg
dri
wt
epicatechin
appar
activ
human
cancer
reportedli
may
promot
apoptosi
arrest
metastasi
inhibit
metalloproteinas
impair
angiogenesi
revers
multidrug
resist
although
epicatechin
except
ec
potenti
suppress
cell
prolifer
egcg
appear
promis
therefor
clinic
investig
chemoprevent
trial
howev
given
wide
rang
physiolog
potenc
differ
catechin
exclus
focu
egcg
probabl
shortsight
egcg
reportedli
effect
egc
decreas
intestin
absorpt
cholesterol
potent
catechin
inhibitor
revers
transcriptas
ecg
strongest
collagenas
inhibitori
effect
highest
antioxid
potenti
contrast
egc
potent
mediat
oxid
modif
inhibitor
xanthin
oxidas
hepat
catabol
purin
hypothes
vitro
anticanc
action
variou
catechin
vari
type
stage
malign
test
hypothesi
examin
prolifer
catechintr
cell
line
deriv
organconfin
metastat
prostat
cancer
cap
moder
poorli
differenti
epitheli
ovarian
cancer
eoc
goal
obtain
data
would
use
develop
chemoprevent
therapeut
clinic
trial
patient
genderspecif
nonspecif
solid
tumor
four
genderspecif
human
cancer
cell
line
use
androgenreceptorneg
cap
cell
line
develop
hoag
cancer
center
newport
beach
ca
organconfin
primari
tumor
resect
previous
untreat
caucasian
tumor
gleason
grade
evid
vascular
perineur
invas
extracapsular
extens
stage
metastat
cap
cell
line
american
type
cultur
collect
line
deriv
brain
lesion
male
caucasian
androgen
insensit
express
prostatespecif
antigen
two
eoc
cell
line
develop
hoag
cancer
center
also
use
poorli
differenti
clear
cell
grade
carcinoma
omentum
left
ovari
caucasian
femal
moder
differenti
metastat
cell
recov
abdomin
fluid
asian
femal
four
cell
line
cryopreserv
liquid
nitrogen
freezer
recoveri
cryopreserv
cell
vial
transfer
water
bath
thaw
room
temperatur
transfer
ml
polypropylen
tube
pasteur
pipett
aliquot
ml
fetal
bovin
serum
fb
ad
drop
cell
allow
settl
min
centrifug
min
g
supernat
remov
cell
suspend
fresh
rpmi
gentli
tap
vortex
cell
viabil
monitor
trypan
blue
dye
exclus
cell
count
determin
use
hemocytomet
cell
recov
cryovial
grown
glutamin
invitrogen
carlsbad
ca
supplement
fb
hepe
buffer
gentamycin
mg
fungizon
mg
humidifi
atmospher
upon
confluenc
cell
detach
steril
edtadextros
mm
sodium
chlorid
mm
potassium
chlorid
mm
dextros
mm
ethylen
diamin
tetra
acet
edta
mm
sodium
bicarbon
min
min
recov
cold
fb
resuspend
medium
use
trypsin
avoid
harvest
cell
cell
viabil
cell
count
reassess
cell
seed
cultur
flask
epicatechin
use
studi
fig
obtain
sigma
ec
sigma
fw
ecg
sigma
fw
egc
sigma
fw
egc
sigma
fw
pure
assess
highperform
liquid
chromatographi
commerci
sourc
stock
solut
prepar
steril
condit
epicatechin
epicatechin
control
glutamin
invitrogen
fb
hepe
buffer
gentamycin
mg
fungizon
mg
experi
use
ml
steril
polystyren
tissu
cultur
flask
vent
blue
plug
seal
cap
beckton
dickinson
franklin
lake
nj
cat
flask
contain
stock
solut
without
epicatechin
concentr
five
flask
epicatechin
five
flask
control
three
flask
epicatechin
three
flask
control
cell
suspend
ml
solut
describ
transfer
flask
allow
grow
control
cell
reach
confluenc
cell
detach
steril
edtadextros
min
recov
cold
medium
resuspend
medium
cell
count
use
hemocytomet
trypan
blue
dye
exclus
use
determin
number
viabl
versu
dead
cell
interv
seed
confluent
growth
control
cell
use
calcul
doubl
time
number
cell
cycl
inhibitori
concentr
catechin
cell
line
calcul
use
softwar
program
microc
origin
corp
originlab
corpor
northampton
cell
photograph
directli
flask
use
light
microscopi
olympu
japan
analys
varianc
fisher
least
signific
differ
lsd
method
use
pairwis
comparison
valu
signific
level
organconfin
prostat
cancer
cell
line
primari
metastat
epitheli
ovarian
cancer
cell
line
seed
cell
flask
without
variou
concentr
ecg
egcg
photograph
light
microscop
untreat
control
cell
reach
confluenc
fig
ecg
egcg
significantli
affect
densiti
cell
line
decreas
cell
densiti
higher
concentr
much
pronounc
ecg
egcg
find
signific
consid
recommend
clinic
trial
egcg
mean
densiti
viabl
cell
number
million
n
per
treatment
differ
cell
line
examin
without
catechin
fig
cell
densiti
measur
growth
untreat
cell
reach
confluenc
statist
analysi
anova
well
pairwis
comparison
show
ecg
egcg
significantli
affect
cell
densiti
ecg
decreas
cell
densiti
prostat
cancer
cell
ovarian
cancer
cell
line
potent
egcg
egcg
inhibit
growth
ovarian
cancer
cell
line
better
ecg
suggest
need
determin
rel
efficaci
ecg
egcg
clinic
trial
differ
cancer
figur
show
influenc
four
epicatechin
cell
doubl
time
ecg
andor
egcg
prolong
doubl
time
cap
cell
line
eoc
line
doubl
observ
cell
treat
ecg
instead
cell
number
decreas
indic
cell
death
tabl
summar
effect
ec
ecg
egc
egcg
viabil
doubl
time
cycl
four
cell
line
untreat
cell
line
reach
confluenc
cell
cycl
ec
affect
prolifer
cell
reduc
prolifer
cell
half
p
prevent
confluent
growth
tabl
egc
affect
prolifer
cell
line
tabl
wherea
egcg
arrest
prolifer
four
line
ecg
follow
egcg
potent
inhibitor
cell
growth
cycl
prolifer
cell
line
n
per
treatment
monitor
without
ecg
egcg
concentr
dosimetr
result
plot
fig
show
concentrationdepend
suppress
cell
growth
ecg
egcg
suppress
effect
cell
densiti
strike
higher
concentr
ecg
egcg
ecg
potent
inhibitor
cell
growth
egcg
egcg
cell
number
significantli
higher
control
valu
base
result
plot
fig
valu
calcul
valu
ecg
versu
egcg
tabl
ecg
suppress
growth
higher
concentr
test
fig
wherea
egcg
significantli
p
enhanc
prolifer
cap
cell
find
relev
chemoprevent
trial
egcg
green
tea
wide
consum
japan
china
polyphenol
compon
chemoprevent
effect
cancer
vitro
vivo
cup
green
tea
contain
mg
catechin
ec
egc
ecg
egcg
although
numer
investig
shown
role
egcg
cancer
chemoprevent
studi
attempt
compar
rel
antitumor
efficaci
four
catechin
tabl
use
systemat
approach
assess
effect
variou
catechin
cell
line
deriv
genderbas
cancer
found
catechin
antitumor
activ
depend
type
tumor
egcg
alway
potent
chemoprevent
agent
earlier
literatur
tabl
indic
egcg
potent
growth
inhibitor
cell
line
glioblastoma
melanoma
cancer
breast
colon
lung
prostat
androgenreceptorposit
pancrea
liver
mouth
egcg
prevent
prolifer
cell
arrest
cell
cycl
gupta
other
document
arrest
independ
mutat
egcg
treatment
induc
cyclin
kinas
inhibitor
observ
suggest
egcg
impos
cellcycl
checkpoint
howev
result
show
ecg
may
potent
egcg
inhibit
primari
metastat
cap
eoc
cell
fig
tabl
ecg
significantli
reduc
cell
prolifer
tabl
fig
increas
mean
doubl
time
tabl
fig
vitro
effect
chemoprevent
agent
studi
tumor
cell
matrix
suspens
use
suspens
method
expos
entir
cell
surfac
chemotherapeut
agent
find
confirm
earlier
report
use
matrix
method
show
ecg
potent
egcg
suppress
prolifer
cap
cell
thu
report
differ
rel
efficaci
differ
catechin
may
due
differ
methodolog
tumor
cell
kill
catechin
studi
ecg
induc
death
cell
doubl
ecg
concentr
might
increas
tumor
kill
rate
ecg
epimer
cg
vitro
dose
equival
mg
ecegc
mg
egcgecg
far
less
mg
egcg
one
cup
green
tea
howev
lee
et
al
report
plasma
level
egcg
egc
healthi
volunt
increas
ng
respect
min
drink
brew
green
tea
g
tea
solid
ml
hot
water
suggest
drink
cup
green
tea
may
necessari
maintain
plasma
concentr
egcg
equival
use
vitro
dose
mg
kaegi
suggest
daili
intak
cup
green
tea
chemoprevent
measur
level
tea
consumpt
impract
high
chemoprevent
cancer
catechin
may
requir
administr
appropri
catechin
purifi
form
conclus
may
state
green
black
tea
polyphenol
import
compon
antitumor
aspect
complementari
altern
medicin
cam
play
signific
role
american
health
care
system
patient
suffer
chronic
problem
green
tea
catechin
gallat
egcg
ecg
possess
potent
antitumor
activ
epim
commonli
found
black
tea
act
potent
inhibitor
proteas
involv
replic
virus
includ
coronovirus
need
understand
prevent
therapeut
potenti
catechin
gallat
green
black
tea
current
design
phase
chemoprevent
studi
examin
effect
purifi
egcg
ecg
patient
chosen
observ
manag
organconfin
prostat
cancer
